GobyMeds vs Hers: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

GobyMeds beats Hers overall, scoring 8.4/10 vs 7.3/10. GobyMeds is more affordable at $169/mo vs $199/mo. Choose GobyMeds for budget-conscious users who want a modern, well-reviewed comp. Choose Hers for women who want brand-name wegovy (injection or pill) at $149.

A side-by-side comparison of GobyMeds and Hers covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

GobyMeds

#5 of 48

8.4/10

Fast-growing compounded GLP-1 provider with strong Reddit reviews, competitive pricing, and a clean user experience that punches above its price point.

Visit GobyMeds

Hers

#35 of 48

7.3/10

The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership — alongside their existing compounded semaglutide and new compounded tirzepatide programs.

Visit Hers

Feature	GobyMeds	Hers
Our Score	8.4/10	7.3/10
Starting Price	$169/mo	$199/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Budget-conscious users who want a modern, well-reviewed compounded GLP-1 program	Women who want brand-name Wegovy (injection or pill) at $149/mo via the 2026 Novo Nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand
Ranking	#5	#35

Pros & Cons Compared

GobyMeds

Pros

+$119/mo starting price is among the most affordable for a full-service compounded program
+Consistently positive Reddit reviews citing fast shipping, responsive support, and clean UX
+Modern patient portal with real-time order tracking and easy provider messaging
+Quick onboarding — most patients approved and shipped within 48 hours of enrollment

Cons

−Compounded semaglutide only — no tirzepatide, no brand-name, no oral options
−Newer company with less track record than established players like Ro or Hims
−No insurance billing and no superbills for FSA/HSA reimbursement

Hers

Pros

+2026 Novo Nordisk partnership — FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
+Zepbound access via the Lilly/Hims-Hers partnership announced 2026
+Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
+Broader women's health platform — integrates weight loss with hormonal, skin, and wellness services

Cons

−Membership + medication are billed separately ($39 first month / $149 ongoing membership) — watch the all-in math
−Generic support experience — large patient volume means less personalized attention
−Compounded pricing starts at $199/mo but stepped pricing applies at higher doses
−Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership — read as access, not value

Our Verdict

GobyMeds edges out Hers with a score of 8.4/10 vs 7.3/10. If budget is your priority, GobyMeds starts at $169/mo compared to Hers's $199/mo. Choose GobyMeds if you want: budget-conscious users who want a modern, well-reviewed compounded glp-1 program. Choose Hers if you want: women who want brand-name wegovy (injection or pill) at $149/mo via the 2026 novo nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither GobyMeds nor Hers feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review